127 related articles for article (PubMed ID: 35916535)
1. Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).
Vats A; Trejo-Cerro O; Massimi P; Banks L
J Virol; 2022 Aug; 96(16):e0066322. PubMed ID: 35916535
[TBL] [Abstract][Full Text] [Related]
2. Warts, cancer and ubiquitylation: lessons from the papillomaviruses.
Howley PM
Trans Am Clin Climatol Assoc; 2006; 117():113-26; discussion 126-7. PubMed ID: 18528468
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the human papillomavirus type 18 E6/E6AP ubiquitin ligase complex by the HECT domain-containing protein EDD.
Tomaic V; Pim D; Thomas M; Massimi P; Myers MP; Banks L
J Virol; 2011 Apr; 85(7):3120-7. PubMed ID: 21228227
[TBL] [Abstract][Full Text] [Related]
4. HPV E6, E6AP and cervical cancer.
Beaudenon S; Huibregtse JM
BMC Biochem; 2008 Oct; 9 Suppl 1(Suppl 1):S4. PubMed ID: 19007434
[TBL] [Abstract][Full Text] [Related]
5. The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase.
Kelley ML; Keiger KE; Lee CJ; Huibregtse JM
J Virol; 2005 Mar; 79(6):3737-47. PubMed ID: 15731267
[TBL] [Abstract][Full Text] [Related]
6. Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein.
Brimer N; Lyons C; Vande Pol SB
Virology; 2007 Feb; 358(2):303-10. PubMed ID: 17023019
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms of MmuPV1 E6 and E7 and Implications for Human Disease.
Romero-Masters JC; Lambert PF; Munger K
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298698
[TBL] [Abstract][Full Text] [Related]
8. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.
Zanier K; ould M'hamed ould Sidi A; Boulade-Ladame C; Rybin V; Chappelle A; Atkinson A; Kieffer B; Travé G
Structure; 2012 Apr; 20(4):604-17. PubMed ID: 22483108
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into the functional mechanism of the ubiquitin ligase E6AP.
Wang Z; Fan F; Li Z; Ye F; Wang Q; Gao R; Qiu J; Lv Y; Lin M; Xu W; Luo C; Yu X
Nat Commun; 2024 Apr; 15(1):3531. PubMed ID: 38670961
[TBL] [Abstract][Full Text] [Related]
10. The degradation of Rap1GAP via E6AP-mediated ubiquitin-proteasome pathway is associated with HPV16/18-infection in cervical cancer cells.
Wang Y; Xie Y; Sun B; Guo Y; Song L; Mohammednur DE; Zhao C
Infect Agent Cancer; 2021 Dec; 16(1):71. PubMed ID: 34952616
[TBL] [Abstract][Full Text] [Related]
11. Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.
Martínez-Noël G; Galligan JT; Sowa ME; Arndt V; Overton TM; Harper JW; Howley PM
Mol Cell Biol; 2012 Aug; 32(15):3095-106. PubMed ID: 22645313
[TBL] [Abstract][Full Text] [Related]
12. Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins.
Jing M; Bohl J; Brimer N; Kinter M; Vande Pol SB
J Virol; 2007 Mar; 81(5):2231-9. PubMed ID: 17166906
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus E6 and E7 oncoproteins affect the expression of cancer-related microRNAs: additional evidence in HPV-induced tumorigenesis.
Chiantore MV; Mangino G; Iuliano M; Zangrillo MS; De Lillis I; Vaccari G; Accardi R; Tommasino M; Columba Cabezas S; Federico M; Fiorucci G; Romeo G
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1751-63. PubMed ID: 27300513
[TBL] [Abstract][Full Text] [Related]
14. Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer.
Huang X; Huo L; Xiao B; Ouyang Y; Chen F; Li J; Zheng X; Wei D; Wu Y; Zhang R; Cao X; Kang T; Gao Y
Cell Death Differ; 2024 Jan; 31(1):78-89. PubMed ID: 38007552
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein.
Munakata T; Liang Y; Kim S; McGivern DR; Huibregtse J; Nomoto A; Lemon SM
PLoS Pathog; 2007 Sep; 3(9):1335-47. PubMed ID: 17907805
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6.
Camus S; Menéndez S; Cheok CF; Stevenson LF; Laín S; Lane DP
Oncogene; 2007 Jun; 26(28):4059-70. PubMed ID: 17224909
[TBL] [Abstract][Full Text] [Related]
17. Targeting of HPV E6 at the binding sites to the host-cell E6AP, p53, and the endoplasmic reticulum-resident chaperone, GRP78.
Elfiky AA; Saied HR; Ali MA
J Biomol Struct Dyn; 2023 Oct; ():1-11. PubMed ID: 37837442
[No Abstract] [Full Text] [Related]
18. Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53.
Hengstermann A; D'silva MA; Kuballa P; Butz K; Hoppe-Seyler F; Scheffner M
J Virol; 2005 Jul; 79(14):9296-300. PubMed ID: 15994823
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity.
White EA; Kramer RE; Tan MJ; Hayes SD; Harper JW; Howley PM
J Virol; 2012 Dec; 86(24):13174-86. PubMed ID: 23015706
[TBL] [Abstract][Full Text] [Related]
20. Alterations of UHRF family Expression and was regulated by High Risk Type HPV16 in Uterine Cervical Cancer.
Yoshimoto M; Tokuda A; Eguchi A; Nozawa Y; Mori T; Yaginuma Y
Exp Cell Res; 2024 Apr; 437(2):114018. PubMed ID: 38556072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
